Drugs / DTP-HB-Hib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04071379 | Oct 2020 → Apr 2021 | — | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTP-HB-Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04071379 ↗ |
| Known as | DTP-HB-Hib (Bio Farma) | “Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B” NCT04071379 ↗ |